Navigation Links
Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
Date:3/25/2013

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have developed a small molecule that inhibits STAT3, a protein that causes cancer. This development could impact the treatment of several tumor types, including breast, lung, prostate and others that depend on STAT3 for survival.

The study appeared in the Jan. 15 online issue of Cancer Research, a publication of the American Association for Cancer Research.

"STAT3 has been associated with poor prognosis and resistance to chemotherapy in patients with cancer," explained Said M. Sebti, Ph.D., chair of the Drug Discovery Department at Moffitt. "Two STAT3 molecules need to bind to each other, a process called dimerization, to cause malignancy. We developed a small molecule called S3I-1757 to prevent dimerization by disrupting STAT3-STAT3 binding. Once disrupted, STAT3's ability to help cancer cells survive, grow and invade is neutralized."

"Activated STAT3 contributes to cancer at several levels," said study co-author Nicholas J. Lawrence, Ph.D., senior member of Moffitt's Drug Discovery Department. "It triggers the uncontrolled proliferation, invasion and spread of cancer cells. That makes STAT3 an attractive target for drug discovery and therapy."

STAT3 was first found to be involved in malignant transformation in 1995, but researchers have been unable to develop an inhibitor for the protein. In part, the challenge stemmed from the fact that STAT3-STAT3 binding is a protein-protein interaction involving a large surface area, difficult to target with drug-like small molecules.

The researchers, who had been working on finding an inhibitor for STAT3-STAT3 dimerization for some time, recently overcame that challenge and demonstrated in laboratory studies that S31-1757 was effective in neutralizing STAT3's activity.

"We used several approaches to demonstrate that S31-1757 is able to inhibit malignant transformation by its ability to inhibit the STAT3 function," Sebti said. "These included targeting the ability of STAT3 to bind itself."

Their findings will be presented at the annual AACR meeting in April in Washington, D.C.


'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Genetic risk strategies needed for young, black, female breast cancer patients, Moffitt study shows
2. Moffitt Cancer Center researchers study use of dasatinib for patients with high-risk MDS
3. Cancer doesnt change young girls desire to have children, Moffitt Cancer Center study shows
4. Surgery and radiation improve survival for metastatic gastric cancer patients, Moffitt study shows
5. Moffitt researchers say silencing of retinoblastoma gene regulates differentiation of myeloid cells
6. Moffitt researchers find potential new therapeutic target for treating non-small cell lung cancer
7. Moffitt Cancer Center researchers develop automated breast density test linked to cancer risk
8. Tumor cells engineer acidity to drive cell invasion, Moffitt Cancer Center researchers say
9. New drug improves survival in multiple myeloma relapse, Moffitt Cancer Center researchers say
10. Moffitt study shows smoking cessation more successful for cancer patients who quit before surgery
11. Hispanics leery of health care providers, often avoid cancer screenings, Moffitt study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... the company will provide alerting technology to Central Illinois Health Information Exchange ... million in federal funds as the sole sub-recipient participating with the Illinois ...
(Date:12/5/2016)... ... December 05, 2016 , ... BSI and Brenntag Canada have been appointed by ... distribution of their natural fruits and beverage colorants effective November 1, 2016. ... to our Life Sciences product portfolio,” said Steve Brauer, President of Brenntag Specialties, Inc. ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... U.S. Apple ... nationwide as part of the second annual Apples for Education: Buy an Apple, ... food bank providing healthy food for students to take home to their families; solar ...
(Date:12/5/2016)... ... December 05, 2016 , ... Florida Hospital has named ... Florida Region. McGuinness brings experience in executive leadership and clinical practice, as well ... , In her new role, that officially begins December 12, 2016, she will ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Life Will Never Be The ... family and friends. “Life Will Never Be The Same” is the creation of published ... writing children's books and holds a degree in Christian religion and philosophy from Judson ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Health and Gateway Health proudly announce a dynamic collaboration that ... plan members with specific high risk needs. In ... group of consumers, Wellbridge combines technology and population expertise with ... members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)... , Dec. 5, 2016  New research ... ) Research Institute and the U.S. Department of ... Secretary for Preparedness and Response (ASPR), published online ... that automated pharmacy notifications encourage patients with chronic ... natural disaster. The study also affirms that public-private ...
(Date:12/5/2016)...  BD (Becton, Dickinson and Company) (NYSE: ... demonstrate an enhanced technology platform designed with the ability ... leading Pyxis™ and Alaris™ systems, at this year,s ... being held in Las Vegas ... show that approximately 68 percent of medication errors occur ...
Breaking Medicine Technology: